세계의 비타민 바이오마커 시장 보고서(2025년)
Vitamin Biomarkers Global Market Report 2025
상품코드 : 1717355
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,487,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,376,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,266,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

비타민 바이오마커 시장 규모는 향후 수년간 급성장이 전망될 예정입니다. 예측 기간의 성장은 웰니스에 대한 소비자의 관심 증가에 기인하는 것으로 예측됩니다. 예측 기간의 주요 동향으로는 웨어러블 건강 기술의 통합, 멀티 바이오마커 패널의 개발, 고성능 스크리닝법의 진보, 신규 바이오마커 기반의 검사법의 개발, 디지털과 원격 건강 모니터링의 강화 등을 들 수 있습니다.

영양 부족의 유병률 증가는 비타민 바이오마커 시장의 성장을 가속할 것으로 예측됩니다. 비타민 바이오마커는 혈액에서 특정 비타민을 측정하여 영양 상태를 평가하고 적절한 개입을 유도하여 이러한 결핍증을 진단하는 데 도움이 됩니다. 예를 들어, 이탈리아에 본부를 둔 비영리 단체인 식량농업기구의 2023년 7월 보고서에 따르면, 건강하고 활동적인 삶을 위한 최소 에너지 요구량을 충족하기에 식이 에너지 섭취가 부족한 인구의 비율로 정의되는 영양실조 유병률이 2021년 7.9%에서 2022년 전 세계 인구의 약 9.2%로 증가했다고 합니다. 아프리카에서는 이 유병률이 2021년 19.4%에서 2022년 19.7%로 0.3%포인트 증가했습니다.

맞춤형 의료가 중시되게 되어 향후 몇 년간은 비타민 바이오마커 시장의 확대를 촉진할 것으로 예측됩니다. 개별 유전자 프로파일과 개인의 건강 정보에 따라 치료를 사용자 정의할 수 있습니다. 예를 들어, 2024년 2월, 미국에 본사를 둔 비영리 단체인 맞춤 의학 연합은 2023년에 FDA가 희귀 질환 환자를 위한 16개의 새로운 맞춤 치료제를 승인했으며, 이는 2022년의 6개에서 증가한 수치라고 보고했습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

KTH
영문 목차

영문목차

Vitamin biomarkers are measurable indicators in the body that reflect the levels or status of specific vitamins. They are used to assess an individual's nutritional state and diagnose deficiencies or excesses of certain vitamins. These biomarkers are typically measured through blood, urine, or tissue samples and provide insights into how effectively the body absorbs, metabolizes, and utilizes vitamins.

The main types of vitamin biomarkers include serum retinol (vitamin A), ascorbic acid (vitamin C), serum 25(OH)D (vitamin D), serum alpha-tocopherol (vitamin E), serum prothrombin (vitamin K), serum thiamine diphosphate (vitamin B1), serum riboflavin (vitamin B2), serum niacin (vitamin B3), and serum plasma PLP (vitamin B6), among others. For example, serum retinol, which measures the concentration of vitamin A in the blood, is crucial for vision, immune function, and skin health and helps in diagnosing vitamin A deficiencies or excesses. Products for measuring these biomarkers include analyzers, test kits, reagents, and consumables, using testing methods such as enzyme-linked immunosorbent assays (ELISA), liquid chromatography with tandem mass spectrometry (LC-MS/MS), high-performance liquid chromatography (HPLC), and chemiluminescent immunoassays (CLIA). These products are used by various end users, including hospitals, diagnostic laboratories, ambulatory diagnostic centers, and homecare settings.

The vitamin biomarkers market research report is one of a series of new reports from the business research company that provides vitamin biomarkers market statistics, including vitamin biomarkers industry global market size, regional shares, competitors with an vitamin biomarkers market share, detailed vitamin biomarkers market segments, market trends and opportunities, and any further data you may need to thrive in the vitamin biomarkers industry. This vitamin biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vitamin biomarkers market size has grown rapidly in recent years. It will grow from $3.59 billion in 2024 to $4.06 billion in 2025 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to growing awareness of vitamin deficiencies, increasing prevalence of chronic diseases, rising demand for personalized nutrition, increasing research on nutritional biomarkers, and growing geriatric population.

The vitamin biomarkers market size is expected to see rapid growth in the next few years. It will grow to $6.56 billion in 2029 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to growing adoption of digital health solutions, increasing focus on early disease detection, rising demand for home-based testing kits, increasing healthcare expenditure, and rising consumer interest in health and wellness. Major trends in the forecast period include integration of wearable health technology, development of multi-biomarker panels, advancements in high-throughput screening methods, development of novel biomarker-based tests, and enhanced digital and remote health monitoring.

The rising prevalence of nutrition deficiencies is anticipated to drive growth in the vitamin biomarkers market. Nutrition deficiencies, which result from a lack of essential nutrients in the diet and can lead to adverse health effects, are influenced by poor dietary habits, limited access to diverse foods, and socio-economic factors. Vitamin biomarkers help diagnose these deficiencies by measuring specific vitamins in the blood to assess nutritional status and guide appropriate interventions. For example, a July 2023 report by the Food and Agriculture Organization, an Italy-based non-profit organization, noted that the prevalence of undernourishment defined as the percentage of a population whose dietary energy intake is insufficient to meet minimum energy requirements for a healthy and active life affected about 9.2% of the global population in 2022, up from 7.9% in 2021. In Africa, this prevalence increased by 0.3 percentage points, rising from 19.4% in 2021 to 19.7% in 2022. Consequently, the growing prevalence of nutrition deficiencies is expected to fuel the expansion of the vitamin biomarkers market.

The growing emphasis on personalized medicine is anticipated to drive the expansion of the vitamin biomarkers market in the coming years. Personalized medicine is a healthcare approach that customizes treatment and care strategies based on the unique characteristics, genetics, and needs of each patient. This shift is largely due to advancements in genomics, biotechnology, and data analytics, which allow for treatments to be tailored according to individual genetic profiles and personal health information. Vitamin biomarkers play a crucial role in personalized medicine by offering insights into an individual's nutritional status and metabolic functions, thereby facilitating customized treatment plans to enhance health outcomes. For example, in February 2024, the Personalized Medicine Coalition, a U.S.-based non-profit organization, reported that in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, an increase from six in 2022. The newly approved treatments for 2023 included seven cancer drugs and three for other diseases and conditions. Consequently, the heightened focus on personalized medicine is propelling the growth of the vitamin biomarkers market.

In December 2023, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., a China-based medical equipment manufacturer, acquired a 75% stake in DiaSys Diagnostic Systems GmbH for an undisclosed amount. This acquisition is expected to strengthen Mindray's position in the diagnostic solutions market and broaden its technological capabilities. DiaSys Diagnostic Systems GmbH, based in Germany, specializes in researching and developing a range of biomarkers, including those related to vitamins.

Major companies operating in the vitamin biomarkers market are Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers AG, Roche Diagnostics International Ltd., Agilent Technologies Inc, PerkinElmer Inc, bioMerieux SA, Beckman Coulter Inc, Shimadzu Corporation, QuidelOrtho Corporation, Sysmex Corporation, Waters Corporation, Bio-Rad Laboratories Inc, Tecan Group Ltd, Randox Laboratories Ltd, Ortho Clinical Diagnostics Inc, Molecular Devices LLC, Cambridge Isotope Laboratories Inc, Luminex Corporation, DiaSorin SpA, Analytik Jena AG, SeraCare Life Sciences Inc, Biopanda Reagents Ltd, SiPhox Inc

North America was the largest region in the vitamin biomarkers market in 2024. The regions covered in the vitamin biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the vitamin biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vitamin biomarkers market consists of revenues earned by entities by providing services such as vitamin level testing, diagnostic assessments, nutritional monitoring, and personalized health management to detect deficiencies or excesses of specific vitamins. The market value includes the value of related goods sold by the service provider or included within the service offering. The vitamin biomarkers market also includes sales of diagnostic assays, test kits, laboratory reagents, analytical instruments, and point-of-care devices used to measure and analyze vitamin levels in biological samples. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vitamin Biomarkers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vitamin biomarkers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for vitamin biomarkers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vitamin biomarkers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Vitamin Biomarkers Market Characteristics

3. Vitamin Biomarkers Market Trends And Strategies

4. Vitamin Biomarkers Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Vitamin Biomarkers Growth Analysis And Strategic Analysis Framework

6. Vitamin Biomarkers Market Segmentation

7. Vitamin Biomarkers Market Regional And Country Analysis

8. Asia-Pacific Vitamin Biomarkers Market

9. China Vitamin Biomarkers Market

10. India Vitamin Biomarkers Market

11. Japan Vitamin Biomarkers Market

12. Australia Vitamin Biomarkers Market

13. Indonesia Vitamin Biomarkers Market

14. South Korea Vitamin Biomarkers Market

15. Western Europe Vitamin Biomarkers Market

16. UK Vitamin Biomarkers Market

17. Germany Vitamin Biomarkers Market

18. France Vitamin Biomarkers Market

19. Italy Vitamin Biomarkers Market

20. Spain Vitamin Biomarkers Market

21. Eastern Europe Vitamin Biomarkers Market

22. Russia Vitamin Biomarkers Market

23. North America Vitamin Biomarkers Market

24. USA Vitamin Biomarkers Market

25. Canada Vitamin Biomarkers Market

26. South America Vitamin Biomarkers Market

27. Brazil Vitamin Biomarkers Market

28. Middle East Vitamin Biomarkers Market

29. Africa Vitamin Biomarkers Market

30. Vitamin Biomarkers Market Competitive Landscape And Company Profiles

31. Vitamin Biomarkers Market Other Major And Innovative Companies

32. Global Vitamin Biomarkers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vitamin Biomarkers Market

34. Recent Developments In The Vitamin Biomarkers Market

35. Vitamin Biomarkers Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기